Leveraging fine-scale population structures for precision healthcare

Masahiro Kanai^{1

2}

Affiliations

¹ Broad Institute of MIT and Harvard, Cambridge, MA, USA. mkanai@broadinstitute.org.
² Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA, USA. mkanai@broadinstitute.org.

Comment

Masahiro Kanai. Nat Med. 2023 Jul.

. 2023 Jul;29(7):1611-1612.

doi: 10.1038/s41591-023-02423-3.

Masahiro Kanai^{1

2}

¹ Broad Institute of MIT and Harvard, Cambridge, MA, USA. mkanai@broadinstitute.org.
² Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA, USA. mkanai@broadinstitute.org.

No abstract available

Comment on

Disease risk and healthcare utilization among ancestrally diverse groups in the Los Angeles region.
Caggiano C, Boudaie A, Shemirani R, Mefford J, Petter E, Chiu A, Ercelen D, He R, Tward D, Paul KC, Chang TS, Pasaniuc B, Kenny EE, Shortt JA, Gignoux CR, Balliu B, Arboleda VA, Belbin G, Zaitlen N. Caggiano C, et al. Nat Med. 2023 Jul;29(7):1845-1856. doi: 10.1038/s41591-023-02425-1. Epub 2023 Jul 18. Nat Med. 2023. PMID: 37464048 Free PMC article.

1. Caggiano, C. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02425-1 (2023). - DOI
1. The SIGMA Type 2 Diabetes Consortium. Nature 506, 97–101 (2014). - DOI
1. The SIGMA Type 2 Diabetes Consortium. JAMA 311, 2305–2314 (2014). - DOI - PMC
1. Jbaily, A. et al. Nature 601, 228–233 (2022). - DOI - PubMed
1. Martin, A. R. et al. C. Nat. Genet. 51, 584–591 (2019). - DOI - PubMed - PMC